Frank Pallone (Kevin Dietsch/Pool via AP Images)
August 20, 2021 06:38 AM EDT
Pharma

House com­mit­tee ques­tions Eli Lil­ly, Sanofi and No­vo Nordisk as in­sulin prices re­main 'u­nac­cept­ably high'

Zachary Brennan

Senior Editor

House En­er­gy & Com­merce Com­mit­tee lead­ers sent three let­ters on Thurs­day to ex­ecs at Eli Lil­ly,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Once one of im­muno-on­col­o­gy's next great hopes, CD47 faces fi­nal shots on goal

An­oth­er ma­jor PBM will cut Ab­b­Vie's Hu­mi­ra from its largest com­mer­cial for­mu­la­ries

Fed­er­al agency op­pos­es J&J's new 340B dis­count mod­el, promis­es to take 'ac­tions as war­rant­ed'

Ma­jor Gala­pa­gos in­vestor says it will push board on com­pa­ny's 'per­for­mance' and 's­trate­gic op­por­tu­ni­ties'

Pep­tide biotech MBX sub­mits IPO plans, mak­ing a trio of post-La­bor Day Nas­daq hope­fuls

Mubadala, CBC Group ink $680M deal for UCB’s neu­rol­o­gy and al­ler­gy port­fo­lio in Chi­na

A service from the Financial Times